Make your money go further for just 25p per day

AIM IHT

Coronavirus impact: 30 March - a hint of resilience

Bioventixantibody

The week has started with yet more dividend postponements and cancellations but also some fabulous results from one of the most resilient companies on the stock market.


Bioventix: reliability shines through

Bioventix (LON:BVXP), the developer of high-affinity monoclonal antibodies for applications in clinical diagnostics, has announced excellent interim results for the six months ending 31 December 2019. Revenue rose 21% to £5.3m and pre-tax profit was up 31% to £4.3m. The operating cash inflow was £4m with period end cash £5.5m - cashflows are crucial companies attempt to battle a the period of lockdown.

But Bioventix isn't facing as many challenges as other companies…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alpha Group International

Stonking Small Caps: staggering numbers

20/03/2024 · Company Insights

With a growing product offering and expansion overseas, this founder-led business remains an exciting prospect and continues…


Episode 2 of the Investor’s Champion Podcast

20/01/2024 · Podcasts

In this episode of the Investors Champion Podcast, Chris and Lee run through key news from the stock market. It's…


More on Bioventix

Another AIM offer | Results underwhelm | Tough to value

28/10/2024 · Company Insights

An important week for AIM begins with yet another small AIM company receiving an offer, not…


Investor’s Champion Podcast Easter Special

30/03/2024 · Podcasts

This episode of the Investor's Champion Podcast discusses Donald Trump's latest stock market success, cocoa prices…


More on Flowtech Fluidpower Plc

A distinct lack of Swiss precision

26/01/2021 · Company Insights

Updates covered here include those from a highly-rated creator of textile treatments, which was unfortunately unable…


Coronavirus impact: 8 Sept - fabulous results from this AIM blue chip and much more

08/09/2020 · Company Insights

There were a large number of announcements today, including fabulous results from a fast growing provider of…


More on James Latham

Episode 25 of the Investor’s Champion Podcast

06/07/2024 · Podcasts

In this episode of the Investors Champion Podcast, Chris and Lee start with a discussion on…


Delightful results and special dividend | Bonkers Bargain impresses

28/06/2024 · Company Insights

News covered here includes our assessment of delightfully clean results from one of AIM’s elderly members.…


More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP